PATENT CLAIM ANALYSIS

Application Number: 16091823
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "049000"]

Abstract:
The present invention relates to an agent comprising anion-exchange groups that are suitable for adsorbing bacterial lipopolysaccharides (LPS) and/or lipoteichoic acids (LTA), for use in the prevention and/or treatment of inflammatory conditions and/or diseases of the oral cavity or in the vaginal region. The present invention also relates to a pharmaceutical composition that comprises an agent of this kind and can adhere to mucosa.

Claim (Index 14):
A composition comprising cholestyramine for absorbing and/or eliminating bacterial toxins as part of the prevention and/or treatment of inflammatory conditions and/or diseases of the mucous membranes, in particular in the region of the oral cavity, the inflammatory condition of the oral cavity resulting from an infection of or injury to the oral mucosa or the inflammatory disease of the oral cavity being a periodontal disease.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.39216
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11595530', '11409850', '14921758', '14102171', '10144235']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7141141966224065
- 35 USC 102 Novelty (BERT): 0.4952950312590647
- Combined Prediction Score: 0.6922322800860723
- Mean Citation Score: 229.557124
- Max Citation Score: 261.86072
- Similarity Product: 210.9872079103041

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test